Efficacy and Safety of High-Dose Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration (nAMD): A Systematic Review

Cureus · PMC11847406

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

a possible trendno p-value reported

The change from baseline to six months was borderline (p = 0.079), suggesting a possible trend had there been more data.

also in 633 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.